Market Cap 10.03B P/E - EPS this Y -11.70% Ern Qtrly Grth -
Income -148.63M Forward P/E -48.19 EPS next Y -7.50% 50D Avg Chg 9.00%
Sales 51.52M PEG -1.86 EPS past 5Y - 200D Avg Chg 65.00%
Dividend N/A Price/Book 17.26 EPS next 5Y 30.00% 52W High Chg -32.00%
Recommedations 2.10 Quick Ratio 9.64 Shares Outstanding 72.29M 52W Low Chg 739.00%
Insider Own 10.12% ROA -18.17% Shares Float 61.45M Beta 2.11
Inst Own 81.22% ROE -37.46% Shares Shorted/Prior 3.40M/6.06M Price 138.79
Gross Margin -200.90% Profit Margin -288.47% Avg. Volume 2,242,775 Target Price 138.44
Oper. Margin -291.05% Earnings Date Aug 5 Volume 721,896 Change 1.63%
Intellia Therapeutics, Inc. News
08/02/21 Intellia (NTLA) to Report Q2 Earnings: What's in the Cards?
07/29/21 Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
07/29/21 Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2021 Earnings and Company Updates
07/27/21 Intellia Therapeutics, Inc. (NTLA) Dips More Than Broader Markets: What You Should Know
07/16/21 Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
07/16/21 What Type Of Shareholders Make Up Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) Share Registry?
07/15/21 After Game-Changing Clinical Trial Results, These 2 Cathie Wood Stocks Are Exploding
07/12/21 WHO Issues Framework For Governance For Gene Editing Technologies
07/11/21 Intellia Therapeutics' Next Hurdles After Its Positive Clinical Results
07/10/21 Is It Too Late to Buy Intellia Therapeutics?
07/09/21 A Comprehensive Guide to Genomic ETFs
07/06/21 Hedge Funds Are Cashing Out Of Intellia Therapeutics, Inc. (NTLA)
06:49 AM 2 Reasons to Buy Intellia -- and 1 Big Reason Why I Won't
07/02/21 Stock Market Rally: S&P 500, Nasdaq Hit Highs; Facebook, Tesla, Nio, Intellia, Didi IPO, OPEC+ In Focus
07/02/21 Intellia Therapeutics Announces Closing of $690 Million Public Offering of Common Stock
07/02/21 Here's What Drove Gene Editing Stocks Higher This Week
07/01/21 5 Reasons Alnylam's Still a Top Biotech Stock to Buy Now
06/30/21 German Launch Startup Pitches β€˜Taxi’ to Space: Catalyst Update
06/30/21 Why Intellia Therapeutics Was a Winner on Wednesday

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. The company develops in vivo programs focusing on liver diseases, including transthyretin amyloidosis and hereditary angioedema, as well as other research programs comprising primary hyperoxaluria Type 1, alpha-1 antitrypsin deficiency, and Hemophilia B. Its ex vivo pipeline includes proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune diseases; partnered programs focused on chimeric antigen receptor T cells and hematopoietic stem cells; and acute myeloid leukemia. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc.; Regeneron Pharmaceuticals, Inc.; Ospedale San Raffaele; and GEMoaB Monoconals GmbH. The company was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics, Inc. in July 2014. Intellia Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

NTLA Chatroom

User Image TwitsIsShit Posted - 5 hours ago

$NTLA Wow eerily familiar repeat just got announced to be in the works yesterday... how odd... it's as if we've seen a similar story somewhere before??? https://www.imdb.com/title/tt8488126/

User Image Foxtastic Posted - 8 hours ago

$NTLA Waiting for Buy Signal from UltraAlgo! https://pbs.twimg.com/media/E74JbECXMAQ9xu0.jpg

User Image T8SK1 Posted - 12 hours ago

$NTLA Tweet Trends Today's Change 31 % + https://t8sk.com/NTLA

User Image OGTrades1 Posted - 14 hours ago

$NTLA I told you ! 6.34% down since our short alert. Trading is easy with UltraAlgo.

User Image T8skmod Posted - 14 hours ago

$NTLA Tweet Trends Today's Change 31 % + https://t8sk.com/NTLA

User Image ninja9999 Posted - 15 hours ago

$NTLA πŸ’©πŸ’©πŸ’©πŸ’©πŸ’©πŸ’©πŸ’©

User Image sickeconomics Posted - 17 hours ago

With this week's IPO of $CRBU competition in the gene editing space is heating up. Does $BLUE have the right strategy to compete with $CRSP $NTLA $EDIT and all the rest? https://www.sickeconomics.com/2021/07/26/bluebird-bio-split-two-companies/

User Image SweepCast Posted - 1 day ago

SweepCast alerted: $NTLA with Unusual Options Activity Alerted on $115 PUT Expiring: 08-20-2021 worth 30K🐻 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=NTLA&name=PUT&strike=$115&type=SWEEP&pre=$30K&exp=08-20-2021 🎯 |

User Image StreetwiseReports Posted - 1 day ago

Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot: http://ow.ly/7DMs50FJ2Wq McAlinden Research Partners explores the acceleration of gene-editing technology and notes the market is poised to expand as the World Health Organization (WHO) creates new standards for companies to follow. #biotech #CRISPR #geneediting $ARKG $NTLA $CRSP

User Image SweepCast Posted - 1 day ago

SweepCast alerted: $NTLA with Unusual Options Activity Alerted on $100 PUT Expiring: 08-20-2021 worth 44K🐻 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=NTLA&name=PUT&strike=$100&type=TRADE&pre=$44K&exp=08-20-2021 🎯 |

User Image AlphaRR Posted - 1 day ago

$NBSE I don't really play in the pre product biotech space , with the exception being a potential drug development platform like crispr or rna . I was in $CRSP $NTLA $ALNY way early and way before Cathie $ARKG This is super f* high risk, only $150 mil market cap but a really strong team. In my opinion this can be 100 bagger or it can be a zero if it doesn't work. For those looking for super high risk reward , this is a very strong play. Some want to get in early, that's what I did and put it in all accounts. Safer entries after trials get to phase 2 or 3 , and they will need more money so dilution is coming so after a fundraising. But if u want something at 150 mil cap that has 100 bagger potential this is it, size and risk accordingly

User Image Foxtastic Posted - 1 day ago

$NTLA Awaiting Buy Signal from UltraAlgo! https://pbs.twimg.com/media/E7zNJobWYAEV2qm.jpg

User Image jewell69 Posted - 1 day ago

ok, bought my $NTLA 08/02/2021 11:57:00 Bought 22 NTLA @ 138.88 -3,055.36 now, I'm trying to get out at 193.93

User Image jewell69 Posted - 1 day ago

$NTLA trying to buy 22 at 138.88 now b/a 139.21 x 139.58 low for the day 135.37

User Image TwitsIsShit Posted - 1 day ago

$NTLA who's going to ask about the real possibility of introducing deadly mutations into their test subjects? Anyone?

User Image Papichulito Posted - 1 day ago

$NTLA Just watch: $EDIT $CRSP & $BEAM all jumped after the NTLA news. They all (almost) dropped back to the point to when the news came out. I suggest you buy these companies just before the next news comes out. Bullish but this aint the price, agreed?

User Image OGTrades1 Posted - 1 day ago

$NTLA Waiting for short signal on NTLA

User Image Newsfilter Posted - 1 day ago

$NTLA Intellia co-founder Jennifer Doudna’s life story to become a TV series https://newsfilter.io/a/6e4e9f5deffba7f47645dd938d6c44b9

User Image SweepCast Posted - 2 days ago

SweepCast alerted: $NTLA with Unusual Options Activity Alerted on $100 PUT Expiring: 08-20-2021 worth 44K🐻 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=NTLA&name=PUT&strike=$100&type=TRADE&pre=$44K&exp=08-20-2021 🎯 |

User Image SweepCast Posted - 2 days ago

SweepCast alerted: $NTLA with Unusual Options Activity Alerted on $100 PUT Expiring: 08-20-2021 worth 44K🐻 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=NTLA&name=PUT&strike=$100&type=TRADE&pre=$44K&exp=08-20-2021 🎯 |

User Image WSFacts Posted - 2 days ago

$NTLA: Here is the latest forecast and market data for Intellia Therapeutics Inc http://dlvr.it/S4rrSw

User Image GoodOldBenny Posted - 2 days ago

$SPY If u like gene editing stocks ($CRSP, $NTLA $BEAM), you must own $MXCT! Excellent thread here: https://twitter.com/saharainvesting/status/1392492200978694144?s=19

User Image SweepCast Posted - 2 days ago

SweepCast alerted: $NTLA with Unusual Options Activity Alerted on $100 PUT Expiring: 08-20-2021 worth 44K🐻 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=NTLA&name=PUT&strike=$100&type=TRADE&pre=$44K&exp=08-20-2021 🎯 |

User Image Syds_Trading_Club Posted - 2 days ago

$NTLA is still trying to emerge from its bullish consolidation. I am looking for a rally into the middle $170s.

User Image Retirewealthy Posted - 2 days ago

$DTIL when will this hit $NTLA , $BEAM and $EDIT prices? $DTIL has underperformed in share price compared to the other 3.

User Image Foxtastic Posted - 2 days ago

$NTLA Awaiting for Short Signal from UltraAlgo. https://pbs.twimg.com/media/E7jsTYJXIAMB1xZ.jpg

User Image WSFacts Posted - 2 days ago

$NTLA: Investors are talking about the forecast for Intellia Therapeutics Inc http://dlvr.it/S4qVGT

User Image WSFacts Posted - 07/31/21

$NTLA: Here is the latest forecast and market data for Intellia Therapeutics Inc http://dlvr.it/S4pP5K

User Image SweepCast Posted - 07/31/21

SweepCast alerted: $NTLA with Unusual Options Activity Alerted on $100 PUT Expiring: 08-20-2021 worth 44K🐻 |🎯 See More And Start Today https://www.sweepcast.com/optionflow?symbol=NTLA&name=PUT&strike=$100&type=TRADE&pre=$44K&exp=08-20-2021 🎯 |

User Image WSFacts Posted - 07/31/21

$NTLA: Here is the latest forecast and market data for Intellia Therapeutics Inc http://dlvr.it/S4mmKq

Analyst Ratings
Oppenheimer Perform Jun 29, 21
Raymond James Outperform Jun 29, 21
Wedbush Neutral Jun 28, 21
Barclays Overweight Jun 28, 21
Goldman Sachs Buy Jun 28, 21
Truist Securities Buy Jun 28, 21
Roth Capital Buy Jun 28, 21
HC Wainwright & Co. Buy Jun 28, 21
Chardan Capital Buy Jun 28, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
FORMELA JEAN FRANCOIS Director Director Apr 28, 7:51 PM Sell 85.89 342,962 29,457,006 769,614
LEONARD JOHN M President and.. President and CEO Apr 15, 8:50 PM Option 10.36 25,937 268,707 719,305
DORSA CAROLINE Director Director Apr 6, 6:09 PM Option 6.4 7,500 48,000 12,910
DORSA CAROLINE Director Director Apr 6, 6:09 PM Sell 82.28 7,500 617,100 5,410
LEONARD JOHN M President and.. President and CEO Apr 2, 8:46 PM Option 13.99 71,041 993,864 707,263
LEONARD JOHN M President and.. President and CEO Apr 2, 8:46 PM Sell 83.5 38,209 3,190,452 693,368
Rivera Jose E EVP, General.. EVP, General Counsel Apr 2, 8:42 PM Option 13.4 97,001 1,299,813 178,077
Rivera Jose E EVP, General.. EVP, General Counsel Apr 2, 8:42 PM Sell 82.98 50,455 4,186,756 162,388
Rivera Jose E EVP, General.. EVP, General Counsel Feb 9, 8:38 PM Sell 75 11,489 861,675 117,920
Rivera Jose E EVP, General.. EVP, General Counsel Feb 9, 8:38 PM Option 18.3 21,000 384,300 129,409
LEONARD JOHN M President and.. President and CEO Feb 9, 8:36 PM Option 10.12 96,718 978,786 688,579
LEONARD JOHN M President and.. President and CEO Feb 9, 8:36 PM Sell 69.71 50,985 3,554,164 660,536
LEONARD JOHN M President and.. President and CEO Feb 3, 9:39 PM Option 16.41 317,060 5,202,955 651,661
LEONARD JOHN M President and.. President and CEO Feb 3, 9:39 PM Sell 65.34 177,745 11,613,858 614,803
Rivera Jose E EVP, General.. EVP, General Counsel Feb 3, 9:38 PM Option 11.76 109,000 1,281,840 113,876
Rivera Jose E EVP, General.. EVP, General Counsel Feb 3, 9:38 PM Sell 64.19 54,659 3,508,561 108,409
SCHIERMEIER ANDREW EVP, Chief Op.. EVP, Chief Operating Officer Jan 5, 8:58 PM Option 0 4,792 18,033
SCHIERMEIER ANDREW EVP, Chief Op.. EVP, Chief Operating Officer Jan 5, 8:58 PM Sell 55.86 1,377 76,919 16,656
KARSEN PERRY A Director Director Dec 18, 4:29 PM Option 18.53 88,764 1,644,797 93,764
KARSEN PERRY A Director Director Dec 18, 4:29 PM Sell 53.51 88,764 4,749,762 5,000
Rivera Jose E EVP, General.. EVP, General Counsel Dec 3, 6:42 PM Option 13.88 5,000 69,400 52,072
Rivera Jose E EVP, General.. EVP, General Counsel Dec 3, 6:42 PM Sell 38.56 3,364 129,716 48,708
LEONARD JOHN M President and.. President and CEO Nov 27, 9:00 PM Option 16.44 35,000 575,400 487,352
LEONARD JOHN M President and.. President and CEO Nov 27, 9:00 PM Sell 38.5 35,000 1,347,500 467,352
LEONARD JOHN M President and.. President and CEO Nov 25, 8:02 PM Option 6.83 50,000 341,500 517,352
LEONARD JOHN M President and.. President and CEO Nov 25, 8:02 PM Sell 36 50,000 1,800,000 467,352
LEONARD JOHN M President and.. President and CEO Nov 18, 7:56 PM Option 14.58 20,000 291,600 487,352
LEONARD JOHN M President and.. President and CEO Nov 18, 7:56 PM Sell 34 20,000 680,000 467,352
Rivera Jose E EVP, General.. EVP, General Counsel Nov 18, 7:55 PM Option 14.48 11,410 165,217 47,696
Rivera Jose E EVP, General.. EVP, General Counsel Nov 18, 7:55 PM Sell 34.57 6,653 229,994 47,072
Rivera Jose E EVP, General.. EVP, General Counsel Nov 6, 4:41 PM Option 13.88 5,000 69,400 45,679
Rivera Jose E EVP, General.. EVP, General Counsel Nov 6, 4:41 PM Sell 28 3,364 94,192 42,315
LEONARD JOHN M President and.. President and CEO Nov 6, 4:38 PM Option 6.83 50,000 341,500 517,352
LEONARD JOHN M President and.. President and CEO Nov 6, 4:38 PM Sell 26 50,000 1,300,000 467,352
Rivera Jose E EVP, General.. EVP, General Counsel Oct 16, 8:58 PM Option 6.83 10,000 68,300 46,294
Rivera Jose E EVP, General.. EVP, General Counsel Oct 16, 8:58 PM Sell 24.37 5,615 136,838 40,679
Rivera Jose E EVP, General.. EVP, General Counsel Sep 17, 4:55 PM Option 6.83 10,000 68,300 41,909